人子宫内膜癌细胞 Ishikawa

细胞名称

人子宫内膜癌细胞 Ishikawa

货物编码

BFN60805245

产品规格

T25培养瓶x1

1.5ml冻存管x2

细胞数量

1x10^6

1x10^6

保存温度

37℃

-198℃

运输方式

常温保温运输

干冰运输

安全等级

1

用途限制

仅供科研 1类

培养体系

DMEM高糖+10%FBS+1%双抗

培养温度

37℃

二氧化碳浓度

5%

简介

人子宫内膜癌细胞 Ishikawa细胞来源于39岁患有子宫内膜腺癌的女性，表达ER、PR。有报道称该细胞可产生促肾上腺皮质激素释放激素，胎盘碱性磷酸酶、绒膜促性腺激素.该细胞引种自ECACC

注释

Part of: ENCODE project common cell types; tier 3.

Doubling time: 36 hours (at 9th passage), 29 hours (at 40th passage), 27 hours (at 50th passage) (DOI=10.1007/978-4-431-53981-0_2); 35.14 +- 2.68 hours (PubMed=23255909).

Omics: Array-based CGH.

Omics: SNP array analysis.

Omics: Transcriptome analysis.

Misspelling: Ischikawaa; Occasionally.

STR信息

Amelogenin X

CSF1PO 11,12

D2S1338 20

D3S1358 15,17

D5S818 10,11

D7S820 9,10

D8S1179 12,16

D13S317 9,12

D16S539 9

D18S51 13,19

D19S433 12.2,14

D21S11 28

FGA 21

Penta D 10,11

Penta E 11,19

TH01 9,10

TPOX 8

vWA 14,17

参考文献

PubMed=22710073; DOI=10.1016/j.ygyno.2012.06.017

Korch C., Spillman M.A., Jackson T.A., Jacobsen B.M., Murphy S.K., Lessey B.A., Jordan V.C., Bradford A.P.

DNA profiling analysis of endometrial and ovarian cell lines reveals misidentification, redundancy and contamination.

Gynecol. Oncol. 127:241-248(2012)

PubMed=23255909; DOI=10.3892/ol.2012.975

Zhao S.-Z., Li G.-X., Yang L., Li L., Li H.-Y.

Response-specific progestin resistance in a newly characterized Ishikawa human endometrial cancer subcell line resulting from long-term exposure to medroxyprogesterone acetate.

Oncol. Lett. 5:139-144(2013)

PubMed=27397505; DOI=10.1016/j.cell.2016.06.017

Iorio F., Knijnenburg T.A., Vis D.J., Bignell G.R., Menden M.P., Schubert M., Aben N., Goncalves E., Barthorpe S., Lightfoot H., Cokelaer T., Greninger P., van Dyk E., Chang H., de Silva H., Heyn H., Deng X., Egan R.K., Liu Q., Mironenko T., Mitropoulos X., Richardson L., Wang J., Zhang T., Moran S., Sayols S., Soleimani M., Tamborero D., Lopez-Bigas N., Ross-Macdonald P., Esteller M., Gray N.S., Haber D.A., Stratton M.R., Benes C.H., Wessels L.F.A., Saez-Rodriguez J., McDermott U., Garnett M.J.

A landscape of pharmacogenomic interactions in cancer.

Cell 166:740-754(2016)